Modulation of Immune Cell Functions by the E3 Ligase Cbl-b.

Modulation of Immune Cell Functions by the E3 Ligase Cbl-b.
复制标题

通过E3连接酶CBL-B调节免疫细胞功能。

DOI:
10.3389/fonc.2015.00058
复制
发表时间:
2015
影响因子:
4.7
通讯作者:
Sopper S
Sopper S
中科院分区:
医学3区
文献类型:
--
作者:
Lutz-Nicoladoni C;Wolf D;Sopper S

文献摘要

参考文献

被引文献

相似文献

维持免疫耐受是免疫系统的一个重要标志。到目前为止,已经描述了平衡免疫细胞激活和抑制输入所必需的几个信号检查点,其中E3连接酶Cbl-b似乎是一个核心角色。Cbl-b在所有白细胞亚群中表达,并调节T细胞、NK细胞、B细胞和不同类型的髓细胞中的几种信号通路。在大多数情况下,Cbl-b通过抗原或模式识别受体和共刺激分子负性调节激活信号。与此功能一致,cblb缺陷免疫细胞表现出较低的激活阈值,cblb敲除小鼠自发产生自身免疫,并且对实验性自身免疫高度敏感。有趣的是,遗传关联研究也将人类的cblb多态性与自身免疫联系起来。反之亦然,缺陷细胞激活电位的增加使它们更有能力对抗恶性肿瘤或感染。因此,一些报道表明,cblb敲除小鼠排斥肿瘤,主要依赖于细胞毒性T和NK细胞。因此,靶向Cbl-b可能是一种有趣的增强抗癌免疫的策略。在本文中,我们综述了在不同细胞类型中关于细胞再生酶b的分子功能的研究结果,并阐述了细胞再生酶b作为免疫调节治疗靶点的潜力。
Maintenance of immunological tolerance is a critical hallmark of the immune system. Several signaling checkpoints necessary to balance activating and inhibitory input to immune cells have been described so far, among which the E3 ligase Cbl-b appears to be a central player. Cbl-b is expressed in all leukocyte subsets and regulates several signaling pathways in T cells, NK cells, B cells, and different types of myeloid cells. In most cases, Cbl-b negatively regulates activation signals through antigen or pattern recognition receptors and co-stimulatory molecules. In line with this function, cblb-deficient immune cells display lower activation thresholds and cblb knockout mice spontaneously develop autoimmunity and are highly susceptible to experimental autoimmunity. Interestingly, genetic association studies link CBLB-polymorphisms with autoimmunity also in humans. Vice versa, the increased activation potential of cblb-deficient cells renders them more potent to fight against malignancies or infections. Accordingly, several reports have shown that cblb knockout mice reject tumors, which mainly depends on cytotoxic T and NK cells. Thus, targeting Cbl-b may be an interesting strategy to enhance anti-cancer immunity. In this review, we summarize the findings on the molecular function of Cbl-b in different cell types and illustrate the potential of Cbl-b as target for immunomodulatory therapies.
DOI: 10.1038/nature04753
发表时间: 2006-05-11
期刊: NATURE
影响因子: 64.8
作者:
Bettelli, E;Carrier, YJ;Kuchroo, VK
通讯作者: Kuchroo, VK
DOI: 10.2337/db12-0677
发表时间: 2013-06
期刊: Diabetes
影响因子: 7.7
作者:
Abe T;Hirasaka K;Kagawa S;Kohno S;Ochi A;Utsunomiya K;Sakai A;Ohno A;Teshima-Kondo S;Okumura Y;Oarada M;Maekawa Y;Terao J;Mills EM;Nikawa T
通讯作者: Nikawa T
DOI: 10.1186/1471-2350-13-95
发表时间: 2012-10-09
影响因子: --
作者:
DeWan AT;Egan KB;Hellenbrand K;Sorrentino K;Pizzoferrato N;Walsh KM;Bracken MB
通讯作者: Bracken MB
DOI: 10.1172/jci29472
发表时间: 2007-04-01
影响因子: 15.9
作者:
Chiang, Jeffrey Y.;Jang, Ihn Kyung;Gu, Hua
通讯作者: Gu, Hua
DOI: 10.1111/1756-185x.12509
发表时间: 2016-12-01
影响因子: 2.5
作者:
Banica, Leontina M.;Besliu, Alina N.;Matache, Cristiana
通讯作者: Matache, Cristiana